C. Oliva | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where C. Oliva is active.

Explore More

Publication

Featured researches published by C. Oliva.

Anti-Cancer Drugs | 1995

Stability of ifosfamide in solutions for multiday infusion by external pump

Leonello Leone; Alessandro Comandone; C. Oliva; Paolo Bussi; Franca Goffredo; Sergio Bretti; Cesare Bumma

The stability of ifosfamide in Ringer lactate buffer solution either alone or mixed with mesna at 37 degrees C for a 7-day period was analyzed by HPLC. This study was performed to investigate the feasibility of continuous infusion of ifosfamide by a multiday pump in order to reduce the toxicity and to increase the production of active alkylating metabolites of the parent drug. The total decay of ifosfamide activity did not exceed 3.2% at day 7. We conclude that ifosfamide can be safely delivered in a 7-day infusion with no significant loss of activity.

Journal of Chemotherapy | 1998

Pharmacokinetics of ifosfamide administered according to three different schedules in metastatic soft tissue and bone sarcomas.

Alessandro Comandone; L. Leone; C. Oliva; S. Frustaci; M. Monteleone; A.M. Colussi; O. Dal Canton; P. Bergnolo; Antonella Boglione; C. Bumma

Anticancer Research | 2000

Low dose adriamycin and ifosfamide in the treatment of advanced adult soft tissue sarcomas

Alessandro Comandone; Bretti S; Oscar Bertetto; C. Oliva; P. Bergnolo; Bumma C

Journal of Clinical Oncology | 2005

Capecitabine and oxaliplatin: A phase II study with a new schedule of administration in elderly patients with advanced colorectal cancer

Alessandro Comandone; P. Pochettino; P. Bergnolo; Antonella Boglione; O. Dal Canton; S. Chiado Cutin; F. Garetto; M. Biscardi; C. Oliva

Journal of Cancer Research and Clinical Oncology | 2010

Vinorelbine and fluorouracil plus leucovorin combination (ViFL) in patients with anthracycline and taxane-pretreated metastatic breast cancer: a phase II study

C. Oliva; P. Bergnolo; Manuela Inguì; Lavinia Bianco; P. Pochettino; Simona Chiadò Cutin; Antonella Boglione; Orietta Dal Canton; F. Garetto; Alessandro Comandone

Annals of Oncology | 2015

C11Diagnostic and therapeutic pathways in Head & Neck sarcomas (H&NS): an effective example of good clinical practice in Piedmontese Oncologic Network

Alessandro Comandone; Antonella Boglione; P. Pochettino; O. Dal Canton; C. Oliva; F. Garetto; P. Bergnolo; Davide Ottaviani; S. Chiado Cutin

ASCO Meeting Abstracts | 2015

Impact of an home-based program of physical activity on chemotherapy induced delayed nausea and on chemotherapy related fatigue.

C. Oliva; Maria Vietti; P. Bergnolo; Antonella Boglione; Simona Chiadò Cutin; Orietta Dal Canton; F. Garetto; Davide Ottaviani; P. Pochettino; Alessandro Comandone

Journal of Clinical Oncology | 2014

Two different doses of fulvestrant (F) as second- or further-line hormone therapy (HT) in elderly patients with metastatic breast cancer (MBC).

Alessandro Comandone; C. Oliva; Antonella Boglione; Orietta Dal Canton; Simona Chiadò Cutin; P. Pochettino; F. Garetto; Davide Ottaviani; Maria Luisa Sartori; Elena Giubellino; P. Bergnolo

Journal of Clinical Oncology | 2011

Predictive role of topoisomerase IIα, gp170, Bcl-2, tumor burden, and histology in neoadjuvant chemotherapy for soft tissue sarcomas of the extremities.

Alessandro Comandone; P. Porrino; E. Berardengo; A. Linari; Antonella Boglione; C. Oliva; G. Gino; Carlo Faletti; P. Bergnolo; P. Pochettino; A. Bernardi; E. M. Brach del Prever; Raimondo Piana

Anticancer Research | 2008

Weekly irinotecan plus protracted venous fluorouracil infusion (WI-FI) in advanced colorectal cancer: a phase II study.

C. Oliva; P. Pochettino; P. Bergnolo; Antonella Boglione; Simona Chiadò Cutin; Manuela Inguì; Orietta Dal Canton; F. Garetto; Manuela Biscardi; Elisa Berno; Alessandro Comandone

Explore More